What is the treatment for isoniazid-induced peripheral neuropathy?

Treatment of Isoniazid-Induced Peripheral Neuropathy

Pyridoxine (vitamin B6) supplementation is the primary treatment for isoniazid-induced peripheral neuropathy, with recommended doses of 50-100 mg daily until symptoms resolve. 1

Pathophysiology and Mechanism

• Isoniazid competitively inhibits the action of pyridoxine in metabolic functions, leading to deficiency in pyridoxal phosphate (the active form of vitamin B6), which is essential for nerve function 2
• This deficiency causes axonal degeneration and disruption of nerve fibers, particularly affecting motor neurons that supply distal muscles 1
• The neuropathy is dose-dependent and more common in slow acetylators of isoniazid 3

Clinical Presentation

• Symptoms typically begin with numbness and paresthesia in the extremities 1
• May progress to loss of distal sensation, motor ataxia, weakness, and loss of deep tendon reflexes 1, 4
• Motor symptoms can be prominent, with significant weakness of lower limbs 4

Treatment Protocol

Immediate Management

• Administer pyridoxine supplementation at doses of 50-100 mg daily 1
• Consider temporary discontinuation of isoniazid in severe cases 5, 4
• If isoniazid must be continued (e.g., in drug-resistant TB), maintain pyridoxine supplementation at higher doses 4

Medication Options for Symptomatic Relief

• For neuropathic pain, consider:
  • First-line: Duloxetine 30-60 mg daily 1
  • Second-line: Pregabalin 150-600 mg daily or gabapentin 300-2,400 mg daily 1
  • For persistent pain: Tramadol for chronic pain management 1

Non-Pharmacological Interventions

• Recommend wearing loose-fitting shoes and cotton socks 1
• Encourage regular walking to help blood circulation in the feet 1
• Suggest soaking feet in cold water and massage for temporary pain relief 1

Prevention Strategies

• Prophylactic pyridoxine (10-25 mg daily) should be given to all patients on isoniazid who are at high risk of developing neuropathy 1
• High-risk groups include:
  • Patients with diabetes, uremia, alcoholism, or malnutrition 1
  • HIV-positive individuals 1
  • Pregnant women 1
  • Patients with seizure disorders 1
  • Malnourished individuals 5

Monitoring and Follow-up

• Regular clinical assessment for symptoms of peripheral neuropathy in all patients on isoniazid therapy 1
• More frequent monitoring for high-risk patients 1
• Assess for improvement in symptoms after initiating treatment 4

Prognosis

• Most cases of isoniazid-induced peripheral neuropathy are reversible with appropriate pyridoxine supplementation 4, 3
• Improvement typically begins within 2-3 weeks of starting pyridoxine treatment 5, 4
• Some patients may have persistent mild sensory impairment even after treatment 4

Important Considerations and Pitfalls

• Do not use excessive doses of pyridoxine (>200 mg daily) as this can itself cause peripheral neuropathy 1, 6
• Patients with renal insufficiency or on low-protein diets are at higher risk of pyridoxine toxicity 1
• High doses of vitamin C should be avoided as they may interfere with isoniazid metabolism 1
• Even patients on standard isoniazid doses (5 mg/kg) can develop neuropathy if they have risk factors 5, 4
• Peripheral neuropathy can occur even after months of well-tolerated isoniazid therapy 1, 4